Navigation Links
Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
Date:12/29/2008

dicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics and therapeutic tools, which is unproven and may never lead to commercially accepted products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop and commercialize its candidate tools, products and services; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta's technology; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.

Contact: Media & Investors, Ron Kamienchick, T: +1-(646)-509-1893, E:

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
2. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
3. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
4. /C O R R E C T I O N -- Rosetta Genomics Ltd/
5. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
6. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
7. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
8. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
9. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
10. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Rancho BioSciences ... integration of Omicsoft’s Array Suite with tranSMART . ... be able to send data in tranSMART to Array ... all versions of tranSMART including the new 1.2 release. ... visualization and storage for the analysis of high dimensional ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 “Rapid ... automation across the U.S., increasing unemployment, depressing American ... It is a Catch 22—we need automated ... this means fewer jobs,” says economist and corporate ... Pollina Corporate Top 10 Pro-Business States for 2014, ...
(Date:7/31/2014)... The Kidney Cancer Association (KCA) has established a ... Kidney Cancer News. , Bill Bro, KCA CEO, says, ... by an international news organization. When we began using iReport ... This month’s program highlights news of an enzyme that is ... recent study. Kidney Cancer News also presents a report on ...
(Date:7/30/2014)... July 30, 2014 Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... and highlights for the quarter ended June 30, 2014 ... markets close. Regulus will host a ... at 5:00 pm Eastern Daylight Time to discuss its ...
Breaking Biology Technology:Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... ... ... ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... PARK, N.C., Oct. 29 Pharmaceutical Strategic Initiatives® ... in the field of thrombosis and anticoagulation provided ... at a recent symposium held at the XXXIII ... held in Jerusalem, Israel on October 12, 2010. ...
... Oct. 29 Regenicin, Inc. (OTC Bulletin ... in the development of regenerative cell therapies to restore ... that the Company,s Chief Executive Officer, Randall McCoy and ... RetailInvestorConferences.com .DATE: , November 4, 2010TIME: , ...
Cached Biology Technology:Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 2Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 3Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 4Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 5Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 6Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 7Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 8Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 9Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 10Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 12Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 13Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management 2Regenicin to Present Live at RetailInvestorConferences.com on November 4th 2
(Date:7/31/2014)... effect in 1839, humankind has sought to further understand ... purposes. In a new research report published in the ... , scientists may have uncovered a new method ... a naturally occurring combination of lipids that have been ... and across speciessuggests that this specific natural combination of ...
(Date:7/31/2014)... are familiar with Hibiscus flowers- they are an ... are commonly planted in the landscape. Some, like ... endangered species. , Only a relatively few botanists ... an equally beautiful and intriguing related group of ... of Hibiscus". , Brother of Hibiscus species are ...
(Date:7/31/2014)... shown that marine noise can affect animal movement and ... of Bristol and Exeter and the cole Pratique des ... boat noise stops embryonic development and increases larval mortality ... slug Stylocheilus striatus used in this study) ... later feed on toxic alga but this study, conducted ...
Breaking Biology News(10 mins):Scientists shine bright new light on how living things capture energy from the sun 2Brother of Hibiscus is found alive and well on Maui 2Boat noise impacts development and survival of sea hares 2
... University of Florida study following the evolution of lice ... ago, a technology which enabled them to successfully migrate ... associate curator of mammals at the Florida Museum of ... modern humans to better understand human evolution and migration ...
... Calif.) Calling the results "extremely surprising," researchers from ... University report that methane gas concentrations in the Gulf ... months after a massive release occurred following the Deepwater ... study, led by oceanographers John Kessler of Texas A&M ...
... a significant step forward in understanding the atmosphere,s ... some other gases, except carbon dioxide. The issue ... studies suggesting the self-cleaning power of the atmosphere ... others suggest greater stability. And what researchers are ...
Cached Biology News:UF study of lice DNA shows humans first wore clothes 170,000 years ago 2UF study of lice DNA shows humans first wore clothes 170,000 years ago 3UCSB, Texas A&M scientists find methane gas concentrations have returned to near-normal levels 2NOAA-led team measures atmosphere's self-cleaning capacity 2NOAA-led team measures atmosphere's self-cleaning capacity 3
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
... a recombinant human protein produced in E. coli ... RNase A type enzymes. The mode of ... in a 1:1 ratio. The enzyme has been ... and cell types. Addition of the ribonuclease inhibitor ...
... Recombinant RNasin Ribonuclease Inhibitors have broad spectrum ... eukaryotic RNases of the neutral type (1). ... by noncovalently binding to RNases in a ... binding of RNasin Ribonuclease Inhibitor to RNase ...
... acids ,The GC-RICH PCR System, a ... proofreading polymerase, powers through templates that are ... polymerases and other blends of polymerases. The ... unique GC-RICH Resolution Solution combine to deliver ...
Biology Products: